{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:53:34Z","timestamp":1788278014675,"version":"build-2803163510"},"reference-count":129,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.det.2024.04.008","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:05:10Z","timestamp":1717581910000},"page":"577-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adjunctive Management of Itch in Atopic Dermatitis"],"prefix":"10.1016","volume":"42","author":[{"given":"Sarah G.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","article-title":"Public health burden and epidemiology of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib2","doi-asserted-by":"crossref","first-page":"e2021146","DOI":"10.5826\/dpc.1104a146","article-title":"Atopic dermatitis: epidemiology and clinical phenotypes","volume":"11","author":"Raimondo","year":"2021","journal-title":"Dermatol Pract Concept"},{"issue":"12","key":"10.1016\/j.det.2024.04.008_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2340\/00015555-3510","article-title":"Prevalence and incidence of atopic dermatitis: a systematic review","volume":"100","author":"Bylund","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.det.2024.04.008_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1684\/ejd.2023.4449","article-title":"Effect of a novel \"emollient plus\" formulation on mild-to-severe atopic dermatitis and other dry skin-related diseases as monotherapy or adjunctive therapy: an observational study on efficacy, tolerance and quality of life in adult patients","volume":"33","author":"Patsatsi","year":"2023","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2133.2008.08941.x","article-title":"Itch characteristics in atopic dermatitis: results of a web-based questionnaire","volume":"160","author":"Dawn","year":"2009","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","article-title":"Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults","volume":"74","author":"Simpson","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-4362.2002.01436.x","article-title":"Atopic dermatitis is associated with a decrement in health-related quality of life","volume":"41","author":"Kiebert","year":"2002","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.det.2017.02.011","article-title":"Adjunctive management of itch in atopic dermatitis","volume":"35","author":"Elmariah","year":"2017","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5114\/pdia.2013.35619","article-title":"Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use","volume":"30","author":"Gutfreund","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000210746","article-title":"Evaluation of a new method of assessing pruritus and antipruritic drugs","volume":"1","author":"Wahlgren","year":"2009","journal-title":"Skin Pharmacol"},{"issue":"2","key":"10.1016\/j.det.2024.04.008_bib11","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.jaad.2023.08.102","article-title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies","volume":"90","author":"Davis","year":"2023","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/1744666X.2023.2283585","article-title":"A\u00a0critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults","volume":"20","author":"Pezzolo","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.det.2024.04.008_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.sder.2011.04.008","article-title":"Topical therapies for pruritus","volume":"30","author":"Elmariah","year":"2011","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000111134","article-title":"Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation","volume":"21","author":"Breternitz","year":"2008","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib15","first-page":"32","article-title":"Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis","volume":"154","author":"Diluvio","year":"2019","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib16","first-page":"43","article-title":"Anti-inflammatory activities of colloidal oatmeal (Avena sativa) contribute to the effectiveness of oats in treatment of itch associated with dry, irritated skin","volume":"14","author":"Reynertson","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.det.2024.04.008_bib17","first-page":"804","article-title":"Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis","volume":"11","author":"Fowler","year":"2012","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.det.2024.04.008_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00403-008-0858-x","article-title":"Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity","volume":"300","author":"Sur","year":"2008","journal-title":"Arch Dermatol Res"},{"issue":"3 Supplement 1","key":"10.1016\/j.det.2024.04.008_bib19","first-page":"AB67","article-title":"A daily oat-based skin care regimen for atopic skin","volume":"60","author":"Nebus","year":"2009","journal-title":"J Am Acad Derm"},{"issue":"5, Supplement 1","key":"10.1016\/j.det.2024.04.008_bib20","doi-asserted-by":"crossref","first-page":"AB76","DOI":"10.1016\/j.jaad.2015.02.313","article-title":"Therapeutic benefits of an over-the-counter daily moisturizing 1% colloidal oatmeal cream on dry, itchy skin due to atopic dermatitis","volume":"72","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/medicines6030076","article-title":"Breaking the itch-scratch cycle: topical options for the management of chronic cutaneous itch in atopic dermatitis","volume":"6","author":"Harrison","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/ijd.ijd_991_22","article-title":"The efficacy of moisturisers containing ceramide compared with other moisturisers in the management of atopic dermatitis: a systematic literature review and meta-analysis","volume":"68","author":"Nugroho","year":"2023","journal-title":"Indian J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ced\/llad111","article-title":"Atopic dermatitis in skin of colour. Part 1: new discoveries in epidemiology and pathogenesis","volume":"48","author":"Gan","year":"2023","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.det.2024.04.008_bib24","first-page":"657","article-title":"Racial and ethnic variations in skin barrier properties and cultural practices in skin of color newborns, infants, and children","volume":"22","author":"Schachner","year":"2023","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/jamadermatol.2022.6647","article-title":"Trends in the prevalence of eczema among US children by age, sex, race, and ethnicity from 1997 to 2018","volume":"159","author":"Choragudi","year":"2023","journal-title":"JAMA Dermatology"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib26","first-page":"207","article-title":"A\u00a0cohort study on a ceramide-containing cleanser and moisturizer used for atopic dermatitis","volume":"93","author":"Lynde","year":"2014","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib27","first-page":"243","article-title":"Anti-pruritic efficacy of itch relief lotion and cream in patients with atopic history: comparison with hydrocortisone cream","volume":"16","author":"Zirwas","year":"2017","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib28","first-page":"30","article-title":"The efficacy of a ceramide-based cream in mild-to-moderate atopic dermatitis","volume":"11","author":"Draelos","year":"2018","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib29","doi-asserted-by":"crossref","first-page":"e14970","DOI":"10.1111\/dth.14970","article-title":"A\u00a0daily regimen of a ceramide-dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial","volume":"34","author":"Spada","year":"2021","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib30","first-page":"e13017","article-title":"The benefit of a ceramide-linoleic acid-containing moisturizer as an adjunctive therapy for a set of xerotic dermatoses","volume":"32","author":"Yang","year":"2019","journal-title":"Dermatol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.det.2024.04.008_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s40257-020-00538-8","article-title":"The Role of the microbiome and microbiome-derived metabolites in atopic dermatitis and non-histaminergic itch","volume":"21","author":"Li","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib32","first-page":"1190","article-title":"The skin microbiota and itch: is there a link?","volume":"9","author":"Kim","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib33","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2018.09.005","article-title":"Itch: From mechanism to (novel) therapeutic approaches","volume":"142","author":"Yosipovitch","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jid.2017.12.029","article-title":"The genetics of chronic itch: gene expression in the skin of patients with atopic dermatitis and psoriasis with severe itch","volume":"138","author":"Nattkemper","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib36","first-page":"657","article-title":"From probiotic to prebiotic using thermal spring water","volume":"17","author":"Zeichner","year":"2018","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.5021\/ad.2013.25.4.410","article-title":"Staphylococcus aureus colonization in acute and chronic skin lesions of patients with atopic dermatitis","volume":"25","author":"Park","year":"2013","journal-title":"Ann Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1365-2133.2008.08836.x","article-title":"Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study","volume":"159","author":"Gueniche","year":"2008","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib39","first-page":"109","article-title":"The effect of lipopolysaccharide-containing moisturizing cream on skin care in patients with mild atopic dermatitis","volume":"33","author":"Nakai","year":"2019","journal-title":"In\u00a0Vivo"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib40","first-page":"31","article-title":"A\u00a0randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis","volume":"15","author":"Belloni","year":"2005","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2340\/00015555-1531","article-title":"Skin pH: from basic science to basic skin care","volume":"93","author":"Ali","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/JID.2015.363","article-title":"Skin pH is the master switch of kallikrein 5-mediated skin barrier destruction in a murine atopic dermatitis model","volume":"136","author":"Jang","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib43","doi-asserted-by":"crossref","first-page":"e12692","DOI":"10.1111\/dth.12692","article-title":"Short- and long-term effects of two emollients on itching and skin restoration in xerotic eczema","volume":"31","author":"Simon","year":"2018","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2340\/00015555-1916","article-title":"Acid-coated textiles (pH 5.5-6.5)--a new therapeutic strategy for atopic eczema?","volume":"95","author":"Jaeger","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib45","first-page":"970","article-title":"The importance of acidification in atopic eczema: an underexplored avenue for treatment","volume":"4","author":"Panther","year":"2015","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5021\/ad.2016.28.1.126","article-title":"Acidic water bathing could be a safe and effective therapeutic modality for severe and refractory atopic dermatitis","volume":"28","author":"Lee","year":"2016","journal-title":"Ann Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/microorganisms9030527","article-title":"Improvement of atopic dermatitis by synbiotic baths","volume":"9","author":"Noll","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.det.2024.04.008_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000000233","article-title":"Preliminary results on clinical effects of probiotic lactobacillus salivarius LS01 in children affected by atopic dermatitis","volume":"48","author":"Niccoli","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jdermsci.2022.08.001","article-title":"0.005 % hypochlorite reduces serine protease in cultured human keratinocytes: Evidences supporting bleach bath improves atopic dermatitis","volume":"107","author":"Huang","year":"2022","journal-title":"J\u00a0Dermatol Sci"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib50","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1542\/peds.2008-2217","article-title":"Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity","volume":"123","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.anai.2022.03.013","article-title":"Bleach baths for atopic dermatitis: Evidence of efficacy but more data are needed","volume":"128","author":"Paller","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.det.2024.04.008_bib52","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/ijd.16099","article-title":"The role of sodium hypochlorite in atopic dermatitis therapy: a narrative review","volume":"61","author":"Krynicka","year":"2022","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2024.04.008_bib53","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1007\/s00403-023-02723-1","article-title":"Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis","volume":"315","author":"Stolarczyk","year":"2023","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.anai.2022.03.024","article-title":"Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE","volume":"128","author":"Bakaa","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.det.2024.04.008_bib55","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/1346-8138.12265","article-title":"Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia","volume":"40","author":"Wong","year":"2013","journal-title":"J\u00a0Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib57","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1529-8019.2005.00032.x","article-title":"Ultraviolet phototherapy for pruritus","volume":"18","author":"Rivard","year":"2005","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2024.04.008_bib58","doi-asserted-by":"crossref","first-page":"adv9403","DOI":"10.2340\/actadv.v103.9403","article-title":"Narrowband-ultraviolet B vs broadband-ultraviolet B in treatment of chronic pruritus: a randomized, single-blinded, non-inferiority study","volume":"103","author":"Kupsa","year":"2023","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.det.2024.04.008_bib59","first-page":"1120","article-title":"Phototherapy","volume":"16","author":"Singer","year":"2018","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.det.2024.04.008_bib60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.139.2.223","article-title":"Narrowband UV-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis","volume":"139","author":"Legat","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.det.2019.09.001","article-title":"Home UV phototherapy","volume":"38","author":"Jacob","year":"2020","journal-title":"Dermatol Clin"},{"issue":"10","key":"10.1016\/j.det.2024.04.008_bib62","first-page":"Cd013870","article-title":"Phototherapy for atopic eczema","volume":"10","author":"Musters","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12016-010-8225-z","article-title":"Atopic dermatitis and the nervous system","volume":"41","author":"Misery","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.det.2024.04.008_bib64","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/bph.16012","article-title":"Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons","volume":"180","author":"Sun","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.det.2024.04.008_bib65","series-title":"Topical treatments of itching without corticosteroids. Itch mechanisms and management of pruritus","first-page":"383","author":"Litt","year":"1994"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2024.04.008_bib66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(97)80143-0","article-title":"Effect of topical pramoxine on experimentally induced pruritus in humans","volume":"37","author":"Yosipovitch","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib67","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4103\/ijd.ijd_1_21","article-title":"Topical pramoxine in chronic pruritus: where do we stand?","volume":"66","author":"Agarwal","year":"2021","journal-title":"Indian J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2024.04.008_bib68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1185\/03007999709113326","article-title":"Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin","volume":"13","author":"Freitag","year":"1997","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0304-3940(95)11362-Z","article-title":"Effects of menthol and cold on histamine-induced itch and skin reactions in man","volume":"187","author":"Bromm","year":"1995","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(01)02527-7","article-title":"Menthol: a natural analgesic compound","volume":"322","author":"Galeotti","year":"2002","journal-title":"Neurosci Lett"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib71","first-page":"437","article-title":"Safety and antipruritic efficacy of a menthol-containing moisturizing cream","volume":"15","author":"Tey","year":"2017","journal-title":"Skinmed"},{"key":"10.1016\/j.det.2024.04.008_bib72","first-page":"83","article-title":"PA-30 Tolerance profile and efficacy of a menthol-containing itch relief spray in children and atopics","volume":"149","author":"Riser","year":"2003","journal-title":"Br J Dermatol Suppl"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib73","first-page":"98","article-title":"The role of ceramide, menthol, and polidocanol on pruritus, skin barrier function, and disease severity of mild atopic dermatitis","volume":"30","author":"Umborowati","year":"2020","journal-title":"J\u00a0Pak Assoc Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib74","doi-asserted-by":"crossref","first-page":"116","DOI":"10.18433\/J37C7K","article-title":"Monoterpenoids induce agonist-specific desensitization of transient receptor potential vanilloid-3 (TRPV3) ion channels","volume":"12","author":"Sherkheli","year":"2009","journal-title":"J\u00a0Pharm Pharm Sci"},{"issue":"7","key":"10.1016\/j.det.2024.04.008_bib75","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/chemse\/bjt027","article-title":"Camphor activates and sensitizes transient receptor potential melastatin 8 (TRPM8) to cooling and icilin","volume":"38","author":"Selescu","year":"2013","journal-title":"Chem Senses"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib76","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2133.2006.07711.x","article-title":"Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study","volume":"156","author":"Yosipovitch","year":"2007","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jdermsci.2005.01.007","article-title":"Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin","volume":"38","author":"St\u00e4nder","year":"2005","journal-title":"J\u00a0Dermatol Sci"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.det.2024.04.008_bib79","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00105-006-1180-1","article-title":"[Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus]","volume":"57","author":"St\u00e4nder","year":"2006","journal-title":"Hautarzt"},{"key":"10.1016\/j.det.2024.04.008_bib80","first-page":"80","article-title":"Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: A pilot study","volume":"15","author":"Pulvirenti","year":"2007","journal-title":"Acta Dermatovenerol Croat : ADC"},{"issue":"2","key":"10.1016\/j.det.2024.04.008_bib81","doi-asserted-by":"crossref","DOI":"10.5070\/D3272052393","article-title":"Assessing the effects of topical cannabidiol in patients with atopic dermatitis","volume":"27","author":"Maghfour","year":"2021","journal-title":"Dermatol Online J"},{"issue":"12","key":"10.1016\/j.det.2024.04.008_bib82","first-page":"1204","article-title":"An observational study of the application of a topical cannabinoid gel on sensitive dry skin","volume":"19","author":"Maghfour","year":"2020","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib83","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/jdv.13599","article-title":"ETFAD\/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients","volume":"30","author":"Wollenberg","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.det.2024.04.008_bib84","first-page":"1258","article-title":"An evidence-based review of the efficacy of coal tar preparations in the treatment of psoriasis and atopic dermatitis","volume":"9","author":"Slutsky","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.04.008_bib85","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jid.2019.06.142","article-title":"Targeting the cutaneous microbiota in atopic dermatitis by coal tar via AHR-dependent induction of antimicrobial peptides","volume":"140","author":"Smits","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"2","key":"10.1016\/j.det.2024.04.008_bib86","first-page":"917","article-title":"Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis","volume":"123","author":"van den Bogaard","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.det.2024.04.008_bib87","first-page":"590","article-title":"Atopic dermatitis: diagnosis and treatment","volume":"101","author":"Frazier","year":"2020","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib88","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2017.12.077","article-title":"An assessment of the use of antihistamines in the management of atopic dermatitis","volume":"79","author":"He","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib89","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0190-9622(94)70225-X","article-title":"Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. the doxepin study group","volume":"31","author":"Drake","year":"1994","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0190-9622(96)90864-6","article-title":"Self-potentiating allergic contact dermatitis caused by doxepin hydrochloride cream","volume":"34","author":"Shelley","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib91","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000086667","article-title":"Antihistamines in dermatology","volume":"18","author":"Greaves","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study","volume":"89","author":"St\u00e4nder","year":"2009","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.det.2024.04.008_bib93","first-page":"e17260","article-title":"The role of psychiatric, analgesic, and antiepileptic medications in chronic pruritus","volume":"13","author":"Patel","year":"2021","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A\u00a0review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/medicines6030073","article-title":"Mirtazapine for the treatment of chronic pruritus","volume":"6","author":"Khanna","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib96","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","volume":"25","author":"Davis","year":"2003","journal-title":"J\u00a0Pain Symptom Manag"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib97","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/1570159X11311060005","article-title":"Pharmacological inhibition of voltage-gated Ca(2+) channels for chronic pain relief","volume":"11","author":"Lee","year":"2013","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib98","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00403-002-0378-z","article-title":"Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema","volume":"295","author":"J\u00e4rvikallio","year":"2003","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib99","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2133.1990.tb06261.x","article-title":"Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study","volume":"122","author":"Pincelli","year":"1990","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2024.04.008_bib100","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.3390\/ijms23084140","article-title":"Opioidergic signaling\u2014a neglected, yet potentially important player in atopic dermatitis","volume":"23","author":"\u00c1d\u00e1m","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.det.2024.04.008_bib101","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2007.01.007","article-title":"Treatment of pruritus with topically applied opiate receptor antagonist","volume":"56","author":"Bigliardi","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.04.008_bib102","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00105-004-0802-8","article-title":"Antipruritische Therapie mit dem oralen opiatrezeptorantagonisten Naltrexon","volume":"55","author":"Brune","year":"2004","journal-title":"Hautarzt"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib103","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2024.04.008_bib104","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/exd.14669","article-title":"Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits","volume":"31","author":"Kim","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2024.04.008_bib105","doi-asserted-by":"crossref","first-page":"adv00729","DOI":"10.2340\/actadv.v102.2153","article-title":"Evaluating the Effectiveness of Intranasal Butorphanol in Reducing Chronic Itch","volume":"102","author":"Labib","year":"2022","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib106","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib107","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jaci.2023.06.023","article-title":"Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis","volume":"152","author":"Guttman-Yassky","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.det.2024.04.008_bib108","series-title":"Tioga Pharmaceuticals' asimadoline reduces nighttime itching and improves disease-related quality of life in patients with atopic dermatitis [press release]","year":"2017"},{"issue":"10","key":"10.1016\/j.det.2024.04.008_bib109","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s13555-022-00814-x","article-title":"Release of cervical muscle tension improves psychological stress and symptoms of moderate-to-severe atopic dermatitis: a case series with 20 patients","volume":"12","author":"Hosono","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.det.2024.04.008_bib110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neubiorev.2018.01.009","article-title":"The vicious cycle of itch and anxiety","volume":"87","author":"Sanders","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2340\/00015555-1189","article-title":"Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy","volume":"92","author":"Bae","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib112","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1525-1470.1998.tb01374.x","article-title":"Atopic dermatitis symptoms decreased in children following massage therapy","volume":"15","author":"Schachner","year":"1998","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.det.2024.04.008_bib113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ctim.2018.08.013","article-title":"Acupuncture improves symptoms in patients with mild-to-moderate atopic dermatitis: A randomized, sham-controlled preliminary trial","volume":"41","author":"Kang","year":"2018","journal-title":"Compl Ther Med"},{"key":"10.1016\/j.det.2024.04.008_bib114","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbi.2021.01.027","article-title":"Acupuncture ameliorates not only atopic dermatitis-like skin inflammation but also acute and chronic serotonergic itch possibly through blockade of 5-HT2 and 5-HT7 receptors in mice","volume":"93","author":"Park","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1398-9995.2012.02789.x","article-title":"Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial","volume":"67","author":"Pfab","year":"2012","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.det.2024.04.008_bib116","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1468-3083.2010.03585.x","article-title":"Therapeutic and experimental therapeutic studies on acupuncture and itch: review of the literature","volume":"24","author":"Carlsson","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib117","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbalip.2013.09.011","article-title":"Formation and functions of the corneocyte lipid envelope (CLE)","volume":"1841","author":"Elias","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.det.2024.04.008_bib118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2012.01.005","article-title":"Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation","volume":"97","author":"Weylandt","year":"2012","journal-title":"Prostag Other Lipid Mediat"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib119","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/pde.15143","article-title":"The effect of fatty acids, vitamins, and minerals on pediatric atopic dermatitis: A systematic review","volume":"40","author":"Labib","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/0378-6323.42645","article-title":"Evening primrose oil is effective in atopic dermatitis: a randomized placebo-controlled trial","volume":"74","author":"Senapati","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"12","key":"10.1016\/j.det.2024.04.008_bib121","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1346-8138.2007.00391.x","article-title":"Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: A double-blind, placebo-controlled clinical trial","volume":"34","author":"KANEHARA","year":"2007","journal-title":"J\u00a0Dermatol (Tokyo)"},{"issue":"3 Suppl 1","key":"10.1016\/j.det.2024.04.008_bib122","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaad.2017.11.056","article-title":"Phosphodiesterase 4 inhibitors","volume":"78","author":"Zebda","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2024.04.008_bib123","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamadermatol.2019.0008","article-title":"Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and meta-analysis","volume":"155","author":"Yang","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2024.04.008_bib124","series-title":"Arcutis Announces positive results from INTEGUMENT-PED pivotal phase 3 trial of roflumilast cream 0.05% for the treatment of atopic dermatitis in children ages 2 to 5. News release","year":"2023"},{"key":"10.1016\/j.det.2024.04.008_bib125","series-title":"Efficacy and safety of roflumilast cream 0.15% in adults and children aged \u22656 with mild to moderate atopic dermatitis in two phase 3 trials (INTEGUMENT-1 and INTEGUMENT-2). S025","author":"Eichenfield","year":"2023"},{"issue":"4","key":"10.1016\/j.det.2024.04.008_bib126","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archdermatol.2010.34","article-title":"Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results From a Phase 2A, Randomized, Placebo-Controlled Clinical Trial","volume":"146","author":"Bissonnette","year":"2010","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2024.04.008_bib127","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2018.06.047","article-title":"A\u00a0phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis","volume":"80","author":"Peppers","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2024.04.008_bib128","series-title":"Dermavant reports positive topline results from ADORING 2 atopic dermatitis phase 3 trial of VTAMA\u00ae (tapinarof) cream, 1% once daily in adults and children as young as 2 Years old","year":"2023"},{"key":"10.1016\/j.det.2024.04.008_bib129","article-title":"Dermavant reports positive topline results from adoring 1, the second atopic dermatitis phase 3 trial of VTAMA\u00ae (tapinarof) cream, 1% in adults and children as young as 2 years old","volume":"16","year":"2023","journal-title":"Business Wire. May"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863524000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T10:40:55Z","timestamp":1726310455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863524000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0733863524000500"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2024.04.008","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive Management of Itch in Atopic Dermatitis","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2024.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}